Equity Based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
| Total stock-based compensation expense | $ 2.8 | $ 1.5 |
| Dividend yield | 0.00% | 0.00% |
| Aggregate intrinsic value of exercisable options | $ 6.2 | |
| Unrecognized compensation cost related to non-vested options | $ 13.4 | |
| Weighted-average period expected to recognize compensation expense (in years) | 2 years 9 months 18 days | |
| Weighted average grant date fair value of stock options granted (in dollars per share) | $ 6.05 | $ 4.06 |
| Research and Development Expense | ||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
| Total stock-based compensation expense | $ 1.1 | $ 0.6 |
| General and Administrative Expense | ||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
| Total stock-based compensation expense | $ 1.7 | $ 0.8 |
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|